Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(19 sites)

United States

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Cleveland Clinic Foundation - Florida, Weston, Florida

Massachusetts General Hospital, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

NYU Langone Health, Mineola, New York

Columbia University Medical Center, New York, New York

Duke, Durham, North Carolina

Cleveland Clinic, Cleveland, Ohio

St. Luke's University Health Network, Bethlehem, Pennsylvania

Lyndon Baines Johnson General, Houston, Texas

Houston Methodist, Houston, Texas

M D Anderson Cancer Center, Houston, Texas

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Canada

Arthur J.E. Child Comprehensive Cancer Centre - Calgary, Calgary

University Health Network - Princess Margaret Cancer Centre, Toronto

Italy

Sant'Orsola Hospital di Bologna, Bologna

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

Mexico

Instituto Nacional de Cancerología (Mexico), Tlalpan

Netherlands

Amsterdam UMC - Locatie AMC | H5Zuid 154, Amsterdam